Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 6, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.6K

Hepcidin.

Tomas Ganz1

  • 1Department of Medicine and Pathology, David Geffen School of Medicine, University of California.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 12, 2016
PubMed
Summary
This summary is machine-generated.

Hepcidin, an iron-regulating hormone, controls iron levels by interacting with ferroportin. Dysregulation of hepcidin is linked to various iron disorders, making it a key therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia.

Blood·2026
Same author

Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies.

Clinical breast cancer·2026
Same author

Halofuginone suppresses hepcidin by a heparan sulfate-dependent mechanism to treat iron disorders in mice.

Blood advances·2026
Same author

Disease-modifying effects of iron deficiency in mouse models of chronic renal failure.

Blood. Red cells & iron·2026
Same author

VHL, transferrin, and erythropoietin in the regulation of hepcidin.

HemaSphere·2025
Same author

A proposed path to explaining the unexplained anemia of aging.

The journals of gerontology. Series A, Biological sciences and medical sciences·2025
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in management of systemic AL amyloidosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Endocrinology
  • Physiology

Background:

  • Hepcidin is a liver-produced peptide hormone regulating systemic iron homeostasis.
  • It controls iron release from enterocytes, macrophages, and hepatocytes by binding to ferroportin.
  • Hepcidin production is influenced by iron levels, inflammation, and erythropoiesis.

Purpose of the Study:

  • To elucidate the multifaceted roles of hepcidin in iron metabolism.
  • To highlight hepcidin's involvement in both normal physiology and various pathological conditions.
  • To underscore hepcidin as a potential diagnostic and therapeutic target.

Main Methods:

  • The abstract describes established physiological mechanisms and clinical observations.
  • It synthesizes information on hepcidin's regulation and its interactions with ferroportin.

More Related Videos

Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
08:21

Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation

Published on: April 29, 2015

38.1K

Related Experiment Videos

Last Updated: Feb 6, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.6K
Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
08:21

Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation

Published on: April 29, 2015

38.1K
  • It reviews the clinical manifestations of hepcidin dysregulation in different anemias and iron overload disorders.

    • Main Results:

    • Hepcidin deficiency or resistance causes iron overload (e.g., hereditary hemochromatosis).
    • Increased hepcidin contributes to anemia in chronic diseases by limiting iron availability.
    • Hepcidin's regulation involves complex feedback loops including erythroferrone.

    Conclusions:

    • Hepcidin is a central regulator of iron metabolism with critical roles in health and disease.
    • Understanding hepcidin's function is crucial for diagnosing and treating diverse iron disorders.
    • Hepcidin presents a significant target for future therapeutic interventions in iron-related conditions.